Bank of New York Mellon’s Actinium Pharmaceuticals ATNM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $105K | Hold |
|
|||||
|
2024
Q4 | $82.3K | Sell |
|
|||||
|
2024
Q3 | $123K | Sell |
|
|||||
|
2024
Q2 | $639K | Buy |
|
|||||
|
2024
Q1 | $527K | Sell |
|
|||||
|
2023
Q4 | $583K | Sell |
|
|||||
|
2023
Q3 | $691K | Buy |
|
|||||
|
2023
Q2 | $852K | Buy |
|
|||||
|
2023
Q1 | $507K | Sell |
|
|||||
|
2022
Q4 | $628K | Hold |
|
|||||
|
2022
Q3 | $435K | Buy |
|
|||||
|
2022
Q2 | $245K | Hold |
|
|||||
|
2022
Q1 | $259K | Hold |
|
|||||
|
2021
Q4 | $305K | Hold |
|
|||||
|
2021
Q3 | $450K | Hold |
|
|||||
|
2021
Q2 | $402K | Hold |
|
|||||
|
2021
Q1 | $387K | Sell |
|
|||||
|
2020
Q4 | $434K | Buy |
|
|||||
|
2020
Q3 | $412K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $23K | Sell |
|
|||||
|
2018
Q4 | $19K | Hold |
|
|||||
|
2018
Q3 | $36K | Hold |
|
|||||
|
2018
Q2 | $31K | Sell |
|
|||||
|
2018
Q1 | $23K | Buy |
|
|||||
|
2017
Q4 | $35K | Buy |
|
|||||
|
2017
Q3 | $28K | Hold |
|
|||||
|
2017
Q2 | $59K | Hold |
|
|||||
|
2017
Q1 | $73K | Sell |
|
|||||
|
2016
Q4 | $43K | Sell |
|
|||||
|
2016
Q3 | $70K | Sell |
|
|||||
|
2016
Q2 | $171K | Buy |
|
|||||
|
2016
Q1 | $192K | Hold |
|
|||||
|
2015
Q4 | $312K | Buy |
|
|||||
|
2015
Q3 | $46K | Hold |
|
|||||
|
2015
Q2 | $69K | Sell |
|
|||||
|
2015
Q1 | $433K | Buy |
|
|||||
|
2014
Q4 | $467K | Sell |
|
|||||
|
2014
Q3 | $541K | Buy |
|
|||||
|
2014
Q2 | $519K | Buy |
|